Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Eiger Biopharmaceuticals (EIGR)
NASDAQ:EIGR
RESEARCH TOOLSreports
Holding EIGR?
Track your performance easily
| Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 3.80M | $ 3.21M | $ 4.39M | $ 4.12M | $ 2.70M |
| Gross Profit | $ 4.09M | $ 3.21M | $ 4.33M | $ 4.00M | $ 2.35M |
| EBIT | $ -12.03M | $ -16.62M | $ -19.35M | $ -21.50M | $ -24.39M |
| EBITDA | $ -11.53M | - | $ -19.21M | $ -21.32M | $ -23.82M |
| Net Income Common Stockholders | $ -12.83M | $ -18.03M | $ -20.70M | $ -22.78M | $ -25.14M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 25.40M | $ 39.42M | $ 53.63M | $ 75.29M | $ 98.95M |
| Total Assets | $ 38.83M | $ 55.65M | $ 72.38M | $ 98.44M | $ 120.14M |
| Total Debt | $ 41.20M | $ 40.94M | $ 40.67M | $ 40.42M | $ 40.20M |
| Net Debt | $ 15.80M | $ 1.52M | $ -12.96M | $ -34.87M | $ -58.75M |
| Total Liabilities | $ 53.28M | $ 57.26M | $ 57.06M | $ 63.99M | $ 64.83M |
| Stockholders Equity | $ -14.46M | $ -1.60M | $ 15.27M | $ 35.22M | $ 55.31M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -13.95M | - | $ -22.05M | $ -24.22M | $ -22.47M |
| Operating Cash Flow | $ -13.95M | $ -14.56M | $ -22.04M | $ -24.00M | $ -22.25M |
| Investing Cash Flow | $ 12.00M | $ 19.00M | $ 29.85M | $ 13.38M | $ 21.80M |
| Financing Cash Flow | $ 7.00K | $ 15.00K | $ -22.00K | $ 41.00K | $ -60.00K |